Efficacy and safety of adjuvant chemotherapy in T1N0M0 intrahepatic cholangiocarcinoma after radical resection

被引：0
|
作者：
Xiao-hui Li
Chong-yu Zhao
En-liang Zhou
Xiao-jun Lin
机构：
[1] Collaborative Innovation Center for Cancer Medicine,Department of Pancreatobiliary Surgery, State Key Laboratory of Oncology in South China
[2] Sun Yat-sen University Cancer Center,undefined
来源：
BMC Cancer | / 22卷
关键词：
Adjuvant chemotherapy; Adverse reactions; Efficacy; Intrahepatic cholangiocarcinoma; Survival analysis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [41] SURGERY PLUS ADJUVANT CHEMOTHERAPY FOR T1-3N0M0 SMALL-CELL LUNG-CANCER - RATIONALE FOR CURRENT APPROACH
    MACCHIARINI, P
    HARDIN, M
    BASOLO, F
    BRUNO, J
    CHELLA, A
    ANGELETTI, CA
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1991, 14 (03): : 218 - 224
  • [42] Prognostic value of adjuvant chemotherapy for hormone receptor-negative T1a and T1bN0M0 breast cancer patients
    Liu, Yaxiong
    Li, Honghui
    Li, Jinsong
    Wei, Changlong
    Zeng, Jinsheng
    Tian, Qiuhong
    SCIENTIFIC REPORTS, 2025, 15 (01):
  • [43] Is Adjuvant Chemotherapy Beneficial to All Patients With pT3N0M0 Stage Gastric Cancer?
    Huang, Jiao-Bao
    Lu, Jun
    Wu, Dong
    Xu, Bin-bin
    Xue, Zhen
    Lin, Guo-Sheng
    Zheng, Hua-Long
    Shen, Li-Li
    Lin, Jia
    Xie, Jian-Wei
    Wang, Jia-Bin
    Lin, Jian-Xian
    Chen, Qi-Yue
    Cao, Long-Long
    Zheng, Chao-Hui
    Huang, Chang-Ming
    Li, Ping
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [44] Adjuvant Chemotherapy in pT2N0M0 Gastric Cancer: Findings From a Retrospective Study
    Mei, Yu
    Feng, Xijia
    Feng, Tienan
    Yan, Min
    Zhu, Zhenggang
    Li, Tian
    Zhu, Zhenglun
    FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [45] The role of adjuvant chemotherapy in rectal cancer patients with ypT0-2N0 after neoadjuvant chemoradiotherapy
    Yang, Jianguo
    Deng, Qican
    Chen, Zhenzhou
    Chen, Yajun
    Fu, Zhongxue
    FRONTIERS IN ONCOLOGY, 2024, 14
  • [46] Adjuvant chemotherapy in the management of pT3N0M0 transitional cell carcinoma of the upper urinary tract
    Lee, Sang Eun
    Byun, Seok-Soo
    Park, Yong Hyun
    Chang, In Ho
    Kim, Yong June
    Hong, Sung Kyu
    UROLOGIA INTERNATIONALIS, 2006, 77 (01) : 22 - 26
  • [47] The Population-based Impact of Adjuvant Chemotherapy on Outcomes in T2N0M0 Non-Small Cell Lung Cancer
    Arora, Rahul K.
    Gibson, Amanda W.
    Bebb, D. Gwyn
    Cheung, Winson Y.
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2020, 43 (07): : 496 - 503
  • [48] Role of Adjuvant Chemotherapy in Resected T2N0 Gall Bladder Cancer
    Kattepur, Abhay K.
    Patkar, Shraddha
    Goel, Mahesh
    Ramaswamy, Anant
    Ostwal, Vikas
    JOURNAL OF GASTROINTESTINAL SURGERY, 2019, 23 (11) : 2232 - 2238
  • [49] Role of Adjuvant Chemotherapy in Resected T2N0 Gall Bladder Cancer
    Abhay K. Kattepur
    Shraddha Patkar
    Mahesh Goel
    Anant Ramaswamy
    Vikas Ostwal
    Journal of Gastrointestinal Surgery, 2019, 23 : 2232 - 2238
  • [50] Challenges surrounding postoperative adjuvant chemotherapy for T2N0 gastric cancer
    Sun, Ke-Kang
    Wang, Qing-Hua
    Wu, Yong-You
    ONCOLOGY LETTERS, 2020, 20 (05)
12345